NCT01498497View on ClinicalTrials.gov

A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021

CompletedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Eosinophilic Esophagitis
Interventions
DRUG

EUR-1100

DRUG

Placebo

Trial Locations (6)

19104

University of Pennsylvania, Philadelphia

30342

Children's Center for Digestive Health, Atlanta

46202

Riley Hospital for Children, Indianapolis

55905

Mayo Clinic, Rochester

60611

Northwestern University School of Medicine, Chicago

08330

South Jersey Pediatric Gastroenterology, Mays Landing

Sponsors
All Listed Sponsors
lead

Forest Laboratories

INDUSTRY